It is well known that there are abnormalities of the sympathetic nervous system in chronic congestive heart failure. The aim of our study was to verify the effects on heart rate, blood pressure and some echocardiographic parameters of performance and inotropic state of iv infusion of dopamine at different dosages in 14 patients affected by dilated cardiomyopathy. The patients were divided into 3 groups: the first one of patients on standard treatment, the second of subjects on standard treatment and beta blockers, the third of patients who stopped beta blocker therapy and remained on standard therapy. In the first group dopamine at low dosage did not significantly modify heart rate, blood pressure, performance and contractile state, while i...
SUMMARY Twenty-eight patients with heart failure caused by congestive cardiomyopathy, which had been...
Dopamine is widely used in critical care to prevent renal function loss. Nevertheless sufficient evi...
Long-term therapy with oral sympathomimetic amines in patients with heart failure has been limited b...
It is well known that there are abnormalities of the sympathetic nervous system in chronic congestiv...
AbstractAlthough long-term therapy with oral beta-adrenoceptor agonists in patients with heart failu...
AbstractObjectivesThe goal of this work was to study the effects of short-term infusion of dobutamin...
Dopamine is an effective drug in the management of acute congestive heart failure. Its beneficial ac...
Dopamine is an effective drug in the management of acute congestive heart failure. Its beneficial ac...
As an agent potentially capable of inducing ischemia in patients with coronary artery disease, dopam...
SUMMARY The hemodynamic benefits of combining administra-tion of dopamine with nitroprusside (NP) we...
amine), a biochemical precursor of levarter-enol and epinephrine, has been shown in previous studies...
The aim of this study was to investigate whether long-term treatment with ibopamine (SB-7505), the 3...
Twenty-one patients, ri with normal pulmonary artery pressures and Io with pulmonary hypertension, h...
The haemodynamic effects of dobutamine were studied in I4 patients with chronic congestive cardiac f...
The importance of the dopaminergic system in heart failure is unknown and the therapeutic potential ...
SUMMARY Twenty-eight patients with heart failure caused by congestive cardiomyopathy, which had been...
Dopamine is widely used in critical care to prevent renal function loss. Nevertheless sufficient evi...
Long-term therapy with oral sympathomimetic amines in patients with heart failure has been limited b...
It is well known that there are abnormalities of the sympathetic nervous system in chronic congestiv...
AbstractAlthough long-term therapy with oral beta-adrenoceptor agonists in patients with heart failu...
AbstractObjectivesThe goal of this work was to study the effects of short-term infusion of dobutamin...
Dopamine is an effective drug in the management of acute congestive heart failure. Its beneficial ac...
Dopamine is an effective drug in the management of acute congestive heart failure. Its beneficial ac...
As an agent potentially capable of inducing ischemia in patients with coronary artery disease, dopam...
SUMMARY The hemodynamic benefits of combining administra-tion of dopamine with nitroprusside (NP) we...
amine), a biochemical precursor of levarter-enol and epinephrine, has been shown in previous studies...
The aim of this study was to investigate whether long-term treatment with ibopamine (SB-7505), the 3...
Twenty-one patients, ri with normal pulmonary artery pressures and Io with pulmonary hypertension, h...
The haemodynamic effects of dobutamine were studied in I4 patients with chronic congestive cardiac f...
The importance of the dopaminergic system in heart failure is unknown and the therapeutic potential ...
SUMMARY Twenty-eight patients with heart failure caused by congestive cardiomyopathy, which had been...
Dopamine is widely used in critical care to prevent renal function loss. Nevertheless sufficient evi...
Long-term therapy with oral sympathomimetic amines in patients with heart failure has been limited b...